Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals.

Imagine going for a morning run without carrying your smartphone, yet still checking your glucose levels with a glance at your wrist. Thanks to direct-to-watch CGM technology, people using compatible continuous glucose monitors can now check their readings without keeping their phones nearby. This added freedom can make exercise, daily activities, and glucose monitoring more ...

The arrival of Onswik, a new once-weekly basal insulin, gives healthcare professionals another treatment option for adults with type 2 diabetes. Following the FDA approval of Awiqli (insulin icodec-abae) in March 2026, Onswik (insulin efsitora alfa-gobe) received approval in September 2026. Both medications reduce basal insulin injections from seven per week to one. However, ...

Automated insulin delivery (AID) has transformed type 1 diabetes care, but can today's algorithms keep pace with menopause? For women with type 1 diabetes who are approaching or experiencing menopause, changing hormone levels may introduce new challenges in glucose management. Although AID systems can respond to changing glucose readings, they do not directly measure reproduc...

Lower A1C has long been a central goal in diabetes care. However, does achieving tighter glucose control necessarily protect patients from peripheral nerve damage? A recent systematic review suggests the relationship is less straightforward in type 2 diabetes. The findings challenge the idea that lowering A1C alone can prevent diabetic neuropathy and highlight the importance ...

Pregnancy can accelerate diabetic eye disease, but is one trimester more dangerous than another? A 2026 retrospective study examining diabetic retinopathy during pregnancy found that retinal damage could develop or worsen at any stage, with no statistically significant differences in progression between trimesters. These findings suggest clinicians should focus less on identi...